HomeAI · summaries
Storia in 3 fonti
Why researchers are excited about a one-time cholesterol therapy
Discover why a one-time gene-editing cholesterol therapy could transform heart disease prevention
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
arstechnica.com
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
- ·
One dose of gene-editing drug cut bad cholesterol 62% for months in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
